Imeglimin Amplifies Glucose-Stimulated Insulin Release from Diabetic Islets via a Distinct Mechanism of Action
D. Moller, M. Kergoat, P. Fouqueray, S. Bolze, S. Hallakou-Bozec
This study identifies a novel mechanism by which Imeglimin enhances glucose-stimulated insulin release in diabetic islets through NAD+ and cADPR pathways.
PLOS ONE · Feb 19, 2021Peer-reviewedPharmacology & Toxicology